Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for The Meeting Of Board Of Directors Is Scheduled To Be Held On Tuesday, 12Th November 2019.

VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on Tuesday, 12th November 2019 to inter alia consider and approve as below: 1. Unaudited Financial Results for the quarter ended on 30th September, 2019 2. Any other item with the permission of chair. Further, as informed vide letter dated 30.09.2019, the trading window would remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives, in view of the aforesaid Board meeting.
31-10-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Certificate under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
29-10-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s. Link Intime India Pvt Ltd. for the quarter ended 30.09.2019.
18-10-2019
Bigul

Venus Remedies Ltd - 526953 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Venus Remedies Ltd has submitted to BSE a copy of Clarification is enclosed.
18-10-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Clarification sought from Venus Remedies Ltd

The Exchange has sought clarification from Venus Remedies Ltd on 17th October 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
18-10-2019
Bigul

Venus Remedies Ltd - 526953 - Clarification sought from Venus Remedies Ltd

The Exchange has sought clarification from Venus Remedies Ltd on 17th October 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
18-10-2019
Bigul

Cipla acquires anti-infective drug Elores from Venus Remedies

Elores is used to treat life threatening infections
17-10-2019
Bigul

Venus Remedies Ltd - 526953 - Venus Announces Deal With Cipla For Its Patented Product Elores For Indian Territory

Venus announces deal with Cipla for its patented product Elores for Indian Territory
17-10-2019
Bigul

Venus Remedies Ltd - 526953 - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Certificate under regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
15-10-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended September 30, 2019

Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
10-10-2019
Next Page
Close

Let's Open Free Demat Account